Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (DE:471A)
FRANKFURT:471A
Holding DE:471A?
Track your performance easily
aTyr Pharma (471A) Ownership Overview
2.67% Insiders
32.31% Mutual Funds
22.36% Other Institutional Investors
42.66% Public Companies and
Individual Investors
The ownership structure of aTyr Pharma (DE:471A) stock is a mix of institutional, retail and individual investors. Approximately 54.67% of the company’s stock is owned by Institutional Investors, 2.67% is owned by Insiders and 42.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 24, 2024 | Paul Schimmel Director | xxxxxxxxxxxxx | $184402 |
| Jun 03, 2024 | Sanjay Shukla President & Ceo,director | xxxxxxxxxxxxx | $36000 |
| Jun 03, 2024 | Timothy Coughlin Director | xxxxxxxxxxxxx | $87500 |
| Dec 12, 2023 | Sanjay Shukla President & Ceo,director | xxxxxxxxxxxxx | $17550 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $2625732 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,470,000 | Institution | 19.09% | 24,338,540 | |
| 4,394,587 | Institution | 5.80% | 7,391,695 | |
| 2,853,244 | Institution | 3.76% | 4,799,156 | |
| 2,536,244 | Institution | 3.35% | 4,265,962 | |
| 2,258,063 | Institution | 2.98% | 3,798,062 | |
| 1,683,162 | Institution | 2.22% | 2,831,078 | |
| 534,793 | Institution | 0.71% | 899,522 | |
| 159,510 | Institution | 0.21% | 268,296 | |
| 152,582 | Institution | 0.20% | 256,643 | |
| 62,500 | Institution | 0.08% | 105,125 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,470,000 | Institution | 19.09% | 24,338,540 | |
| 4,394,587 | Institution | 5.80% | 7,391,695 | |
| 2,536,244 | Institution | 3.35% | 4,265,962 | |
| 2,258,063 | Institution | 2.98% | 3,798,062 | |
| 534,793 | Institution | 0.71% | 899,522 | |
| 152,582 | Institution | 0.20% | 256,643 | |
| 62,500 | Institution | 0.08% | 105,125 | |
| 38,420 | Institution | 0.05% | 64,622 | |
| 26,689 | Institution | 0.04% | 44,891 | |
| 11,466 | Institution | 0.02% | 19,286 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns aTyr Pharma (DE:471A)?
According to the latest TipRanks data, approximately 22.36% of the company's stock is held by institutional investors, 2.67% is held by insiders, and 42.66% is held by retail investors.
What percentage of aTyr Pharma (DE:471A) stock is held by institutional investors?
According to the latest TipRanks data, approximately 22.36% of aTyr Pharma (DE:471A) stock is held by institutional investors.
What percentage of aTyr Pharma (DE:471A) stock is held by retail investors?
According to the latest TipRanks data, approximately 42.66% of aTyr Pharma (DE:471A) stock is held by retail investors.
Who owns the most shares of aTyr Pharma (DE:471A)?
Federated Hermes Equity Funds owns the most shares of aTyr Pharma (DE:471A).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.